timolol has been researched along with Lung Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CL; Chuang, CH; Liu, HL; Wei, PJ; Yang, CJ | 1 |
| Bhullar, S; Coleman, EL; Leventhal, JS; Olamiju, B | 1 |
2 other study(ies) available for timolol and Lung Neoplasms
| Article | Year |
|---|---|
Combination of available topical beta-blockers and antibiotic ointment for epidermal growth factor receptor tyrosine kinase inhibitor-induced paronychia and pseudopyogenic granulomas in Taiwan.
Topics: Aged; Angiolymphoid Hyperplasia with Eosinophilia; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Female; Humans; Lung Neoplasms; Male; Mutation; Neomycin; Ointments; Ophthalmic Solutions; Paronychia; Protein Kinase Inhibitors; Retrospective Studies; Taiwan; Timolol; Tyrosine Kinase Inhibitors; Tyrothricin | 2023 |
Management of paronychia with pseudopyogenic granulomas secondary to epidermal growth factor receptor inhibitors: An assessment of topical timolol and the need for multiple medical and procedural therapies.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Aged; Angiolymphoid Hyperplasia with Eosinophilia; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cryotherapy; ErbB Receptors; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Paronychia; Protein Kinase Inhibitors; Retrospective Studies; Severity of Illness Index; Silver Nitrate; Timolol; Treatment Outcome | 2021 |